Oncology Innovations and Other Trending Topics from IRB Experts
Oncology has long been an early adopter of research innovations, such as gene therapy, cross-organization collaboration, and novel protocol design, which has both affirmed and propelled ground-breaking contributions in clinical research.
Join colleagues from NCI-designated cancer centers for a discussion on hot topics in oncology research. This expert panel discussion includes both institutional review board (IRB) chairpersons, as well as current and former directors of human research protection programs (HRPP) from academic medical centers. Together, they discuss the unique ways oncology has pioneered clinical trial advancements and explore how IRBs/HRPPs review research involving new treatment options. Additionally, they examine how mainstream attention on clinical trial participation and diversity of volunteers impacts the oncology space in future clinical trials.
Learning Objectives:
- Explore how IRBs/HRPPs review research involving new treatment options
- Discuss diversity, equity, and inclusion (DEI) issues in oncology research
- Outline lessons learned from conducting oncology trials virtually
Presented By
Julie Moore
JD, PA, CIP
Associate Director, Institutional Research Center of Excellence (CoE)
Advarra Consulting
R. Michael Tuttle
MD
IRB Chair and Chief of Endocrinology Service
Memorial Sloan Kettering Cancer Center
David Weber
MD, MPH
Associate Chief Medical Officer & IRB Chair
University of North Carolina
Hallie Kassan
CIP
Director of Human Subjects Protection
MD Anderson Cancer Center
DATE: June 17, 2021
Time: 1 pm ET | 10 am PT
Duration: 1 hour